Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

HCIT: Not at all shocked. Incompetent marketing

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155000
(Total Views: 723)
Posted On: 11/23/2020 2:06:04 PM
Posted By: LOL83001
Re: HCIT #66271
HCIT: Not at all shocked. Incompetent marketing strategy and tactics continues to be the bane of this company. My bet is since NP opened his mouth it'll end up negative by end of day.

"The Force" you refer to is "compelling human interest" and the competition is not some inexplicable nefarious evil- it is simply thousands of other news stories. Failure to properly communicate the importance and significance of this data in is simply piss poor management. Basic marketing 101. How to write a PR.

Look at the structure and context of just this "story". The failure is very easy to spot: This is fantastic news! But they immediately dilute the impact of the news and fail to tell a story. The purpose of a PR is to get real media to pick up the story. So you have to have a story. The best way to get that is to write the story for the reporter/editor.

This PR has:

1) Non-compelling self-centered and run-on title. No media will use that title. Write it for them.
2) Low impact run-on sentences. Re-writing poorly crappy PR copy is a very low priority job for reporters and editors. Write correctly.
3) Highly diluted message with multiple data and no story line, no "focused hook" about the importance of the S/C issue: That even with a vax millions will still get COVID. Reporters/editors do not create news or context; nor have time to research & re-write the core focus of the story.
4) No quote from external/independent references to validate and provide follow up leads. Again, asking reporter/editor to do your job.
5) Diluted story and poor writing not only wrecks the focus of this PR, but totally deflates the value/opportunity to PR updates on LH (huge !) and BLA which are entirely separate and compelling stories in and of themselves. One story at a time- Ohhhmmmmm.




(5)
(1)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us